Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 6 November 2009:
Vol. 326. no. 5954, pp. 853 - 858
DOI: 10.1126/science.1177585

Reports

Small-Molecule Activators of a Proenzyme

Dennis W. Wolan, Julie A. Zorn, Daniel C. Gray, James A. Wells*

Virtually all of the 560 human proteases are stored as inactive proenyzmes and are strictly regulated. We report the identification and characterization of the first small molecules that directly activate proenzymes, the apoptotic procaspases-3 and -6. It is surprising that these compounds induce autoproteolytic activation by stabilizing a conformation that is both more active and more susceptible to intermolecular proteolysis. These procaspase activators bypass the normal upstream proapoptotic signaling cascades and induce rapid apoptosis in a variety of cell lines. Systematic biochemical and biophysical analyses identified a cluster of mutations in procaspase-3 that resist small-molecule activation both in vitro and in cells. Compounds that induce gain of function are rare, and the activators reported here will enable direct control of the executioner caspases in apoptosis and in cellular differentiation. More generally, these studies presage the discovery of other proenzyme activators to explore fundamental processes of proenzyme activation and their fate-determining roles in biology.

Departments of Pharmaceutical Chemistry and Cellular and Molecular Pharmacology, University of California, San Francisco, Byers Hall, 1700 4th Street, San Francisco, CA 94158, USA.

*To whom correspondence should be addressed. E-mail: jim.wells{at}ucsf.edu

Read the Full Text






To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)